SierraSil Joint Formula 14 as an Ergogenic Aid to Performance in Athletes

Muscle Fatigue Clinical Trial

Official title:

SierraSil as an Ergogenic Aid to Performance in Athletes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01932281
• Other study ID #: H13-00121
• Status: Completed
• Phase: N/A
• First received: August 27, 2013
• Last updated: July 13, 2015
• Start date: May 2014
• Est. completion date: September 2014

Study information

• Verified date: July 2015
• Source: University of British Columbia
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Ethics Review Committee
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to examine whether supplementation with SierraSil can improve anaerobic power and reduce muscle fatigue in a group of well-trained athletes.

A secondary purpose is to examine the effect of SierraSil on the severity of delayed onset muscle soreness.

Description:

This is a double blind, crossover, pilot study that will examine the effect of SierraSil supplementation on the determinants of human performance. Anaerobic capacity, muscle fatigue, the severity of delayed onset muscle soreness (DOMS) and markers of inflammation will be measured before and after 3 weeks of supplementation with SierraSil or placebo. There will be a 3 week washout period prior to the crossover to ensure SierraSil supplementation has no residual effect.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: September 2014
• Est. primary completion date: September 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 19 Years to 35 Years

Eligibility

Inclusion Criteria:

• no contraindications to strenuous exercise

Exclusion Criteria:

• muscle or joint injury

• taking any form of anti-inflammatory or pain medication

• females due to the variability that might be introduced due to the phases of the menstrual cycle

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Muscle Fatigue
• Muscle Power

Intervention

Dietary Supplement:
• SierraSil
SierraSil is a natural, mineral supplement currently used to improve joint health and function.
• Placebo
Sugar pill manufactured to mimic SierraSil 667 mg capsule

Locations

Country	Name	City	State
Canada	University of British Columbia	Vancouver	British Columbia

Sponsors (1)

Lead Sponsor	Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change in total anaerobic capacity		change from baseline at 3 weeks	No